المؤلفون: Ferreira, APS, Seguro, FS, Abdo, ARN, Santos, FM, Maciel, FVR, Nardinelli, L, Giorgi, RR, Ruiz, ARL, Rocha, VG, Bendit, I

المصدر: In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S214-S214

المؤلفون: Ahmed Abd Elsalam, Abdo Arnous, Osama Abdelfattah

المصدر: International Journal of Medical Arts, Vol 2, Iss 4, Pp 844-853 (2020)

مصطلحات موضوعية: varicose veins, foam, sclerotherapy, ultrasound-guided, lower limbs, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://ijma.journals.ekb.eg/article_109401_a57ae9f3a77c06a9428a8017b5cff322.pdf; https://doaj.org/toc/2636-4174; https://doaj.org/toc/2682-3780

URL الوصول: https://doaj.org/article/5733ce1401f24dc8b40f09ac4caa669d

المؤلفون: AbduAllah Zidan, Mohammed shahin, Abdo Arnous

المصدر: International Journal of Medical Arts, Vol 2, Iss 3, Pp 572-579 (2020)

مصطلحات موضوعية: congenital, penile curvature, penile mal-rotation, surgery, dorsal flap of dartos layer, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://ijma.journals.ekb.eg/article_101778_ad702a16d141128dab554efa644e0cbf.pdf; https://doaj.org/toc/2636-4174; https://doaj.org/toc/2682-3780

URL الوصول: https://doaj.org/article/540d8c18b0144a3aa342346c7b2036e6

المؤلفون: Ahmad Hassouna, Abdo Arnous, Esam Taman, Ibrahim Elsayaad

المصدر: International Journal of Medical Arts, Vol 2, Iss 3, Pp 508-518 (2020)

مصطلحات موضوعية: snodgrass, urethroplasty, mathieu, hypospadias, congenital, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://ijma.journals.ekb.eg/article_93050_76026fa108efcbee464c11fa0433d815.pdf; https://doaj.org/toc/2636-4174; https://doaj.org/toc/2682-3780

URL الوصول: https://doaj.org/article/b8448943a89a4d4e9c48368be470059e

المؤلفون: Ferreira APS; Hematologica Clinic Oncoclinicas, Belo Horizonte, Brazil.; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil., Seguro FS; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Abdo ARN; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Santos FM; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Maciel FVR; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Hemato‑Oncologia, DASA-Genômica, Sao Paulo, Brazil., Nardinelli L; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Giorgi RR; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Ruiz ARL; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil., Ferreira MPS; Minas Gerais Federal University, Belo Horizonte, Brazil., Rego EM; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Rocha V; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Bendit I; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil. isbendit@usp.br.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil. isbendit@usp.br.; Hemato‑Oncologia, DASA-Genômica, Sao Paulo, Brazil. isbendit@usp.br.

المصدر: Annals of hematology [Ann Hematol] 2023 Jul; Vol. 102 (7), pp. 1969.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Ferreira APS; Hematology Clinic Oncoclinicas, Sao Paulo, Brazil.; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil., Seguro FS; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Abdo ARN; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Santos FM; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Maciel FVR; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Hemato-Oncologia, DASA-Genômica, Sao Paulo, Brazil., Nardinelli L; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Giorgi RR; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Ruiz ARL; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil., Ferreira MPS; Minas Gerais Federal University, Belo Horizonte, Brazil., Rego EM; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Rocha V; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Bendit I; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil. isbendit@usp.br.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil. isbendit@usp.br.; Hemato-Oncologia, DASA-Genômica, Sao Paulo, Brazil. isbendit@usp.br.

المصدر: Annals of hematology [Ann Hematol] 2023 Jul; Vol. 102 (7), pp. 1761-1771. Date of Electronic Publication: 2023 Apr 13.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Antineoplastic Agents*/therapeutic use, Humans ; Imatinib Mesylate/therapeutic use ; Retrospective Studies ; Prospective Studies ; Treatment Outcome ; Protein Kinase Inhibitors/therapeutic use ; Philadelphia Chromosome ; Fusion Proteins, bcr-abl/genetics